Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus
Background. Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control may reduce long-term CVD risk. However, other risk factors such as elevated vascular sympathetic tone and/or endothelial d...
Saved in:
Main Authors: | Bindu Chamarthi, J. Michael Gaziano, Lawrence Blonde, Aaron Vinik, Richard E. Scranton, Michael Ezrokhi, Dean Rutty, Anthony H. Cincotta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2015/157698 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Central Hyperthermia Treated with Bromocriptine
by: P. Natteru, et al.
Published: (2017-01-01) -
Peripartum Cardiomyopathy Presenting with Predominant Left Ventricular Diastolic Dysfunction: Efficacy of Bromocriptine
by: Piercarlo Ballo, et al.
Published: (2012-01-01) -
Association between prior tuberculosis disease and dysglycemia within an HIV-endemic, rural South African population.
by: Alison C Castle, et al.
Published: (2023-01-01) -
The Effects of Bromocriptine on Preventing Postpartum Flare in Systemic Lupus Erythematosus Patients from South China
by: Qiu Qian, et al.
Published: (2015-01-01) -
Sistem Pelacakan Dokumen Berbasis Seluler dan Kode QR
by: Monanta Alfiareza, et al.
Published: (2022-06-01)